Improving kidney transplant access with RaDIANT
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if a special program helps dialysis centers refer more people to large transplant centers for a kidney transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at a dialysis center that works with one of these transplant centers: Emory, Piedmont, Medical University of SC, Duke, or Indiana University.
- You are being referred to or are on the waitlist at one of these transplant centers.
- You are not at a non-participating transplant center.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the effectiveness and resource use of remote patient monitoring across different dialysis methods for people with end-stage renal disease. It aims to see if remote monitoring can improve care and outcomes.
This study tests different treatments for people with advanced kidney disease, including those on dialysis or with a kidney transplant. It aims to find better ways to manage the condition and improve outcomes.
This study tests a program to help Black patients with advanced kidney disease learn about their condition and treatment options. It aims to see if this learning program can improve health outcomes.
This study tests a program to help primary care doctors better screen and manage kidney problems in people with type 2 diabetes. It aims to see if using recommended medicines can slow kidney disease and improve health.
This study tests a program to help people with advanced kidney disease learn about and prepare for a kidney transplant. It is for patients who get kidney care at certain hospitals in New York and speak English or Spanish.
This study tests a program that combines digital tools and in-person guidance to help people get a kidney transplant from a living donor. It aims to increase the number of living donor transplants.
Hear when a new End Stage Renal Disease (ESRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.